North America
International Markets
North America
Toggle North America
International Markets
Toggle International Markets
Europe
Toggle Europe
Comparison of Albuterol Breath-Actuated Inhaler Versus Metered-Dose Inhaler in Participants With Asthma
- Study Title
- Comparison of Single-Dose of Albuterol Breath Activated Inhaler Versus Albuterol Metered Dose Inhaler in Asthmatics
- Teva Identifier
- IXR-404-04-167
- ClinicalTrials.gov Identifier
- NCT00530062
- Study Status
- Completed
- Trial Condition(s)
- Asthma
- Interventions
- Drug: Albuterol-HFA-MDI | Drug: Albuterol-HFA-BAI
Study Description
Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age group
- Child, Adult, Older Adult
- Age Range
- 7 Years to 70 Years
- Trial Duration
- 01/01/2007 - 10/01/2008
- Phase
- Phase 4
